Crocus Technology Investors

18 investors on Angel Roster list Crocus Technology in their portfolio. Most are venture capital firms and investment partner investors, the most common stage is Seed and the largest groups are based in the United States, Australia and France.

Investors are matched on the company name in their portfolio, so companies that share the name Crocus Technology can appear together.

Investors listed
18
With verified email
44%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 18 Crocus Technology investors

The most complete profiles first. Showing 18 of 18.

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Philipp StaufferVerified

    Venture Capital, Strategy Operator, Founder · United States

    SeedPre-SeedEarly Stage VentureAdvertisingHealth CareTelecommunicationsE-commerce

    Portfolio: Prisma, Vantik, Heresy, Emulate and 72 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Claire HouryVerified

    Venture Capital, Private Equity Firm, Investment Partner · France

    E-commerceCybersecuritySportsConsumer Goods

    Portfolio: Mindler, The Agent, Oktogo, Annelutfen.com and 68 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Derek KerrVerified

    Micro VC · Australia

    Health CareTelecommunicationsEnergyInformation Technology (IT)

    Portfolio: Windlab, Elanti Systems, Audinate, ActiveSky Research Pty Ltd and 4 more

    Verified email available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Christian Claussen

    Venture Capital, Private Equity Firm, Investment Partner · Germany

    E-commerceCybersecuritySportsConsumer Goods

    Portfolio: Mindler, The Agent, Oktogo, Annelutfen.com and 68 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Jean Bourcereau

    Venture Capital · France

    E-commerceCybersecuritySportsConsumer Goods

    Portfolio: Mindler, The Agent, Oktogo, Annelutfen.com and 68 more

    Contact details available

  • Nicolas Barthalon

    Venture Capital, Private Equity Firm, Investment Partner · Germany

    E-commerceCybersecuritySportsConsumer Goods

    Portfolio: Mindler, The Agent, Oktogo, Annelutfen.com and 68 more

    Contact details available

  • Tero Mennander

    Venture Capital, Private Equity Firm, Investment Partner · Finland

    E-commerceCybersecuritySportsConsumer Goods

    Portfolio: Mindler, The Agent, Oktogo, Annelutfen.com and 68 more

    Contact details available

  • Aymeric Sallin

    Venture Capital, Founder, CEO · United States

    SeedHealth CareLife ScienceArtificial Intelligence (AI)Software

    Portfolio: H55, Orca Bio, Crocus Technology, View and 3 more

    Contact details available

  • Roger Price

    Micro VC · Australia

    Health CareTelecommunicationsEnergyInformation Technology (IT)

    Portfolio: Windlab, Elanti Systems, Audinate, ActiveSky Research Pty Ltd and 4 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Crocus Technology investors are on Angel Roster?

Angel Roster lists 18 Crocus Technology investors. 8 of them (44%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (16), Investment Partner Investors (5) and Private Equity Firms (4). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Crocus Technology investors invest in?

Among those that list a stage, the most common are Seed (6), Early Stage Venture (1) and Series B (1).

Where are Crocus Technology investors based?

Most are based in the United States (10), Australia (2) and France (2).

Which companies have Crocus Technology investors backed?

The most-backed portfolio companies among them are Versartis (9), Aeovian Pharmaceuticals (9), Ziarco (9), Mirna Therapeutics (9) and ObsEva (9).

How do I contact Crocus Technology investors?

Create a free Angel Roster account to search and filter all 18, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.